Poland· PL-100403746
Oncaspar
A pegaspargase product containing pegasparagasum, registered in Poland by Les Laboratoires Servier. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pegaspargase is registered in 15 of 19 countries.
Countries holding a registration under ATC L01XX24 (pegaspargase), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Pegaspargase · ATC L01XX24
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Pegasparagasum
- Manufacturer
- Les Laboratoires Servier
- Country
- Poland (PL)
- ATC code
- L01XX24
- ATC class
- Pegaspargase
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin00642621070989
- gtin03664898060149
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
441 interactions on record for pegaspargase.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pegaspargase · interactions on record
441 records
- 30 severe
- 411 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ClotrimazoleA01AB18moderate
- Chenodeoxycholic acidA05AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XX24
Pegaspargase, as other registers publish it.
- DenmarkOncasparLes Laboratoires Servier
- NorwayOncasparLes Laboratoires Servier (4)
- FinlandOncasparLes Laboratoires Servier
- FinlandOncasparOrifarm Oy
- FinlandOncasparLes Laboratoires Servier
- DenmarkOncasparLes Laboratoires Servier
- IcelandOncasparLes Laboratoires Servier*
- United StatesONCASPARServier Pharmaceuticals LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2dc3a6cd-4c3b-488c-88b9-b2f11fc4e586 GET /v1/drugs/2dc3a6cd-4c3b-488c-88b9-b2f11fc4e586?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań / do infuzji",
"source": "urpl",
"strength": "750 j./ml",
"packaging": "00642621070989 ¦ Rpz ¦ EU/1/15/1070/002 ¦ 127556\n1 fiol. 3750 j. proszku\n¦ UR/Z/4c/064/22 - 03664898060149 ¦ UR/Z/4c/132/22 - 03664898060149 ¦ UR/Z/4c/066/22 - 03664898060149 ¦ UR/Z/4c/165/22 - 03664898060149 ¦ UR/Z/4c/132/23 - 03664898060149 ¦ UR/Z/4c/017/24 - 03664898060149",
"substance": "Pegasparagasum 750 j./ml",
"common_name": "Pegasparagasum",
"pl_product_id": "100403746",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about pegaspargase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.